Quintrio
Home

PHARMACEUTICAL PREPARATIONS

MIRA Pharmaceuticals, Inc. Common Stock

MIRA

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Last trade $0.65
Day change +$0.019 (+3.01%)
Day range $0.639 – $0.703
Volume 115,790
Market cap $27M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$26.47M
Price / earnings
—
Price / book
3.24×
Price / sales
—
EV / sales
—
EV / EBITDA
-2.43×

Profitability

Earnings per share
-$0.74
Return on assets
-378.35%
Return on equity
-380.24%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
200.08×
Quick ratio
200.08×
Cash ratio
88.42×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$4.64M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for MIRA, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$0$0$0$0$0$0$0$0
Gross profit$0$0$0$0$0$0$0$0
Selling, general and administrative$450.33K$578.7K$5.33M$904.35K$1.05M$1.49M$1.58M$1.01M
Research and development$705.79K$524.78K$496.54K$412.64K$496.2K$314.4K$861.44K$1.07M
Total operating expenses$1.16M$1.1M$5.82M$1.32M$1.55M$1.81M$2.44M$2.08M
Operating income-$1.16M-$1.1M-$5.82M-$1.32M-$1.55M-$1.81M-$2.44M-$2.08M
Interest expense$0$0$53.17K$15.7K$0$0$38.11K$37.75K
Income before taxes-$1.21M-$1.15M-$5.98M-$1.14M-$1.54M-$1.78M-$2.4M-$2.04M
Income taxes$0$0$0$0$0$0$0$0
Net income-$1.21M-$1.15M-$5.98M-$1.14M-$1.54M-$1.78M-$2.4M-$2.04M
Net income attributable to common shareholders-$1.21M-$1.15M-$5.98M-$22.69M-$1.54M-$1.78M-$2.4M-$2.04M
EBITDA-$1.16M-$1.1M-$5.82M-$1.32M-$1.55M-$1.81M-$2.44M-$2.08M
Basic earnings per share-$0.03-$0.03-$0.14-$1.18-$0.09-$0.11-$0.14-$0.14
Diluted earnings per share-$0.03-$0.03-$0.14-$1.18-$0.09-$0.11-$0.14-$0.14

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Why Mira Pharmaceuticals Shares Rose 69% After Hours?

Mira Pharmaceuticals saw significant after-hours stock price increase following preclinical data announcement for Mira-55, a non-psychotropic marijuana compound that demonstrated superior pain reduction compared to morphine in animal studies.

GlobeNewswire Inc.

Kernel and Mira Launch Industry’s First $300M Secured AI API

KernelDAO, a top restaking protocol, has partnered with Mira, a pioneer in trustless verified AI technology, to launch a first-of-its-kind API that enhances AI reliability through trustless verification. The partnership aims to address key challenges in the AI industry, including reducing system downtime and errors through trustless verification.

Benzinga

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Destiny Tech100 Inc (NASDAQ: DXYZ) rose 52.9% to $13.76 in pre-market trading after gaining 9% on Tuesday. PaySign, Inc. (NASDAQ: PAYS) gained 25.2% to $4.23 in pre-market trading after the company announced better-than-expected fourth-quarter results. Hitek Global Inc. (NASDAQ: HKIT) gained 19.1% to $1.69 in pre-market trading. The ONE Group Hospitality, Inc. (NASDAQ: STKS) shares rose 13.2% to $4.54 in pre-market trading after the company announced that it will acquire Safflower Holdings. nCino, Inc. (NASDAQ: NCNO) gained 11.7% to $33.72 in pre-market trading as the company reported better-than-expected fourth-quarter results and issued FY25 adjusted earnings guidance above estimates.. Nuvation Bio Inc. (NASDAQ: NUVB) shares rose 11.5% to $3.21 in pre-market trading. Nuvation Bio shares gained 28% on Tuesday after BTIG upgraded the stock from Neutral ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.